Hims to buy telehealth firm Eucalyptus as it expands internationally
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
FDA’s Høeg plans to scrutinize SSRIs, RSV shots for babies
WASHINGTON — Tracy Beth Høeg, the top drug regulator at the Food and Drug Administration, indicated in her…
COVID-19 Vaccination During Pregnancy Cut Preeclampsia Risk
COVID-19 infection during pregnancy was associated with a 45% increased risk of preeclampsia, which rose to 78% among…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
PhRMA forum shows industry divide between Dr. Oz, Marty Makary
WASHINGTON — Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a…
Israel reluctant to accept new immigrant pharmacists
MK Tatiana Mazarsky (Yesh Atid) criticized the Health Ministry’s requirement that pharmacists immigrating to Israel complete an internship…
Researchers ID Cause of Blood Clots After COVID Vaccines
Scientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after…
FDA rejects drug for rare blood disorder
The US Food and Drug Administration has rejected a small molecule for a rare blood disorder called…
Consumer group presses U.S. to authorize generic GLP-1s
Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs…
CRISPR Unlocks a New Path to Stronger Medicinal Plants
Newswise — Medicinal plants synthesize a wide range of specialized metabolites that form the foundation of many modern…
Crick spin‑out ALTx will target cancer cell immortality
Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies…
Hims is in the crosshairs. What does it mean for compounding?
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…